ResMed | RMD - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Ansell USD 1.97B 10.2M 2025-12
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 491.69M 242K 2026-03
Baxter International USD 6.04B 86M 2026-03
Cochlear AUD 1.94B 12.2M 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
CSL USD 18.66B 2.75B 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Fisher Paykel Healthcare NZD 1.99B 95.8M 2025-12
Globus Medical USD 4.73B 159.06M 2026-03
Haemonetics USD 796.32M 115.13M 2026-03
Idexx Laboratories USD 1.56B 49.28M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.3B 212.6M 2026-03
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
Masimo USD 788.9M 67.7M 2026-03
Medtronic USD 48.99B 128M 2025-12
Philips EUR 11.39B 403M 2026-03
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.49B 171.03M 2026-03
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Steris USD 7.18B 29.1M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03